KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
Holding KALV?
Track your performance easily

KalVista Pharmaceuticals (KALV) Financial Statements

380 Followers

KalVista Pharmaceuticals Financial Overview

KalVista Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-3.535; its P/E ratio is -3.18; KalVista Pharmaceuticals is scheduled to report earnings on December 5, 2024, and the estimated EPS forecast is $-0.93. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Apr 24Jan 24Oct 23Jul 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -40.44M$ -44.65M$ -33.15M$ -27.65M$ -25.32M
EBITDA$ -40.21M$ -44.44M$ -32.94M$ -27.43M$ -25.06M
Net Income Common Stockholders$ -40.44M$ -44.65M$ -29.03M$ -27.65M$ -25.32M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 174.27M$ 210.40M$ 75.59M$ 103.17M$ 123.26M
Total Assets$ 200.20M$ 235.40M$ 113.97M$ 138.74M$ 160.33M
Total Debt$ 6.25M$ 7.32M$ 7.44M$ 7.69M$ 7.99M
Net Debt$ -168.02M$ -203.08M$ -68.14M$ -95.48M$ -115.27M
Total Liabilities$ 27.40M$ 28.82M$ 25.39M$ 24.30M$ 21.00M
Stockholders Equity$ 172.80M$ 206.61M$ 88.58M$ 114.45M$ 139.33M
Cash Flow-
Free Cash Flow$ -40.24M$ -15.12M$ -27.59M$ -19.83M$ -26.74M
Operating Cash Flow$ -40.22M$ -15.11M$ -27.57M$ -19.82M$ -26.73M
Investing Cash Flow$ 37.16M$ -126.19M$ -6.70M$ 28.56M$ 19.61M
Financing Cash Flow$ 3.00M$ 150.10M$ 284.00K$ 128.00K$ 204.00K
Currency in USD

KalVista Pharmaceuticals Earnings and Revenue History

KalVista Pharmaceuticals Debt to Assets

KalVista Pharmaceuticals Cash Flow

KalVista Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis